“…It is the only achiral SSRI currently on the market, selectively inhibiting the neuronal uptake of serotonin. Ruijten et al [1] has reported that fluvoxamine is completely metabolized in rats, hamsters, and mice, and to about 90% in dogs. In their study, the major metabolite in dogs, rats, and hamsters was the carboxylic acid formed by oxidative elimination of the methoxy group.…”